EnteroBiotix is a startup based in the United Kingdom, most recent round Series B, 3 tracked investors.
EnteroBiotix is a company founded in 2015 headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
EnteroBiotix is a clinical-stage biotechnology company developing orally administered microbiome therapeutics for the treatment of gastrointestinal tract and liver diseases, including irritable bowel syndrome and liver cirrhosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.